Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2016 06:47 ET | Source: BioCryst Pharmaceuticals

BioCryst Closes $23 Million Senior Credit Facility

Cash runway extended to early 2018; Facility to be repaid with RAPIVAB revenues RESEARCH TRIANGLE PARK, N.C., Sept. 26, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc....
September 07, 2016 06:58 ET | Source: BioCryst Pharmaceuticals

BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model

RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced positive results from a proof-of-concept study of its broad spectrum...
August 31, 2016 14:40 ET | Source: BioCryst Pharmaceuticals

BioCryst to Present at the Baird 2016 Global Healthcare Conference September 8

RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate...
August 11, 2016 10:18 ET | Source: BioCryst Pharmaceuticals

BioCryst Announces Initiation of the APeX-1 Clinical Trial of BCX7353 for Hereditary Angioedema

RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that it has dosed the first subject in the APeX-1 clinical trial of...
August 04, 2016 06:55 ET | Source: BioCryst Pharmaceuticals

BioCryst Reports Second Quarter 2016 Financial Results

RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the second quarter ended June 30, 2016. “We...
July 21, 2016 07:15 ET | Source: Biocryst Pharmaceuticals

BioCryst to Announce Second Quarter 2016 Financial Results August 4

RESEARCH TRIANGLE PARK, N.C., July 21, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its second quarter 2016 financial results will be released on...
July 05, 2016 07:30 ET | Source: Biocryst Pharmaceuticals

BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases

RESEARCH TRIANGLE PARK, N.C., July 05, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of Allergy and Infectious Diseases (NIAID)...
May 26, 2016 08:55 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at Two Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., May 26, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate...
May 05, 2016 06:44 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Reports First Quarter 2016 Financial Results

RESEARCH TRIANGLE PARK, N.C., May 05, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the first quarter ended March 31, 2016. “We are...
April 21, 2016 06:48 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Announce First Quarter 2016 Financial Results May 5

RESEARCH TRIANGLE PARK, N.C., April 21, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its first quarter 2016 financial results will be released on...